Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs

Clinical Ophthalmology

Volumn 4, Issue 1, 2010, Pages 1137-1143

  Schmier, Jordana K ^a   Lau, Edmund C ^b   Covert, David W ^c  

^a Exponent   (United States)

^b EXPONENT INC   (United States)

^c ALCON RESEARCH LTD   (United States)

Author keywords

Combination; Costs and cost analysis; Drug therapy; Glaucoma; Prostaglandin analogs

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIGLAUCOMA AGENT; BENZALKONIUM CHLORIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIMATOPROST; BRIMONIDINE; BRINZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; DORZOLAMIDE PLUS TIMOLOL; LATANOPROST; MIOTIC AGENT; PROSTAGLANDIN DERIVATIVE; TIMOLOL; TRAVOPROST;

ADJUVANT THERAPY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; FEMALE; GLAUCOMA; GLAUCOMA SURGERY; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; PRESCRIPTION; RETROSPECTIVE STUDY; TREATMENT DURATION;

EID: 78349259801     PISSN: 11775467     EISSN: 11775483     Source Type: Book Series    
DOI: 10.2147/OPTH.S13884     Document Type: Article

References (25)

1. Konstas AG, Maskaleris G, Gratsonidis S, Sardelli C. Compliance and viewpoint of glaucoma patients in Greece. Eye (Lond). 2000;14(Pt 5): 752-756.
2. Yeaw J, Benner JS, Walt JG, Sian S, Smith DB. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm. 2009;15(9):728-740.
3. Friedman DS, Quigley HA, Gelb L, et al. Using pharmacy claims data to study adherence to glaucoma medications: Methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest Ophthalmol Vis Sci. 2007;48(11):5052-5057.
4. Schmier JK, Covert DW, Robin AL. First-year treatment patterns among new initiators of topical prostaglandin analogs. Curr Med Res Opin. 2009;25(4):851-858.
5. Schmier JK, Covert DW, Robin AL. First-year treatment costs among new initiators of topical prostaglandin analogs. Clin Ophthalmol. 2009;3: 637-644.
6. Schmier JK, Covert DW. First-year treatment costs among new initiators of topical prostaglandin analogs: Pooled results. Clin Ophthalmol. 2010;4:437-445.
7. Friedman DS, Hahn SR, Gelb L, et al. Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study. Ophthalmology. 2008; 115(8):1320-1327.
8. Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface disease in glaucoma patients. J Glaucoma. 2008;17(5): 350-355.
9. Fechtner RD, Godfrey DG, Budenz D, Stewart JA, Stewart WC, Jasek MC. Prevalence of ocular surface complaints in glaucoma patients using topical intraocular pressure-lowering medications. Cornea. 2010; 29(6):618-621.
10. Robin AL, Novack GD, Covert DW, Crockett RS, Marcic TS. Adherence in glaucoma: Objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol. 2007;144(4):533-540.
11. Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology. 2009;116 Suppl 11:S30-S36.
12. Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol. 1994;112(11):1446-1154.
13. Robin AL, Covert D. Does adjunctive glaucoma therapy affect adherence to the initial primary therapy? Ophthalmology. 2005;112(5): 863-868.
14. Ramulu PY, Corcoran KJ, Corcoran SL, Robin AL. Utilization of various glaucoma surgeries and procedures in Medicare beneficiaries from 1995 to 2004. Ophthalmology. 2007;114(12):2265-2270.
15. Schmier JK, Covert DW, Lau EC, Robin AL. Trends in annual medicare expenditures for glaucoma surgical procedures from 1997 to 2006. Arch Ophthalmol. 2009;127(7):900-905.
16. American Academy of Ophthalmology. Preferred Practice Pattern. Primary Open-Angle Glaucoma. Limited Revision. San Francisco, CA: American Academy of Ophthalmology; 2003.
17. Fremont AM, Lee PP, Mangione CM, et al. Patterns of care for open-angle glaucoma in managed care. Arch Ophthalmol. 2003;121(6):777-783.
18. Quigley HA, Friedman DS, Hahn SR. Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: The Glaucoma Adherence and Persistency Study. Ophthalmology. 2007; 114(9):1599-1606.
19. Thomson Healthcare. Red Book Drug Topics. Montvale, NJ: Thomson Healthcare; 2009.
20. Physicians' Fee Reference: Comprehensive Fee Report: Milwaukee, WI: Yale Wasserman DMD. Medical Publishers; 2009.
21. Denis P, Lafuma A, Khoshnood B, Mimaud V, Berdeaux G. A meta- analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy. Curr Med Res Opin. 2007;23(3):601-608.
22. Friedman DS, Wolfs RC, O'Colmain BJ, et al. Prevalence of openangle glaucoma among adults in the United States. Arch Ophthalmol. 2004;122(4):532-538.
23. Iskedjian M, Walker JH, Desjardins O, et al. Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: A population based study. Curr Med Res Opin. 2009;25(8):1879-1888.
24. Nutescu EA, Park HY, Walton SM, et al. Factors that influence prescribing within a therapeutic drug class. J Eval Clin Pract. 2005; 11(4):357-365.
25. Schumock GT, Walton SM, Park HY, et al. Factors that influence prescribing decisions. Ann Pharmacother. 2004;38(4):557-562.